Novel Vasopressors in the Treatment of Vasodilatory Shock: A Systematic Review of Angiotensin II, Selepressin, and Terlipressin

Management of Refractory Vasodilatory Shock

(2018) Jacob C. Jentzer et al.   CHEST

Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II

(2018) James A. Tumlin et al.   CRITICAL CARE MEDICINE

6

(2018) Harold Szerlip et al.   CRITICAL CARE MEDICINE

Terlipressin in the treatment of hepatorenal syndrome

(2018) Haiqing Wang et al.   MEDICINE

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016

(2017) Andrew Rhodes et al.   INTENSIVE CARE MEDICINE

The role of vasopressin and the vasopressin type V1a receptor agonist selepressin in septic shock

(2017) Antonio F. Saad et al.   JOURNAL OF CRITICAL CARE

The effect of vasoactive drugs on mortality in patients with severe sepsis and septic shock. A network meta-analysis of randomized trials

(2017) Alessandro Belletti et al.   JOURNAL OF CRITICAL CARE

The impact of esophageal varices on the prognosis of patients with hepatocellular carcinoma after surgical resection: a propensity score matching analysis

(2017) C.-Y. Chang et al.   JOURNAL OF HEPATOLOGY

Angiotensin II for the Treatment of Vasodilatory Shock

(2017) Ashish Khanna et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Selective V1A Receptor Agonist, Selepressin, Is Superior to Arginine Vasopressin and to Norepinephrine in Ovine Septic Shock*

(2016) Xinrong He et al.   CRITICAL CARE MEDICINE

Effects of terlipressin on patients with sepsis via improving tissue blood flow

(2016) Xudong Xiao et al.   JOURNAL OF SURGICAL RESEARCH

A randomized trial comparing terlipressin and noradrenaline in patients with cirrhosis and septic shock

(2016) Ashok Choudhury et al.   LIVER INTERNATIONAL

Serious Adverse Events Associated With Vasopressin and Norepinephrine Infusion in Septic Shock*

(2014) Nattachai Anantasit et al.   CRITICAL CARE MEDICINE

The Selective Vasopressin Type 1a Receptor Agonist Selepressin (FE 202158) Blocks Vascular Leak in Ovine Severe Sepsis*

(2014) Marc O. Maybauer et al.   CRITICAL CARE MEDICINE

Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine

(2014) Maurizio Cecconi et al.   INTENSIVE CARE MEDICINE

High versus Low Blood-Pressure Target in Patients with Septic Shock

(2014) Pierre Asfar et al.   NEW ENGLAND JOURNAL OF MEDICINE

Does high-dose vasopressor therapy in medical intensive care patients indicate what we already suspect?

(2013) S. Sviri et al.   JOURNAL OF CRITICAL CARE

Circulatory Shock

(2013) Jean-Louis Vincent et al.   NEW ENGLAND JOURNAL OF MEDICINE

Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational study

(2012) Christian A. Schmittinger et al.   INTENSIVE CARE MEDICINE

Epidemiology and management of atrial fibrillation in medical and noncardiac surgical adult intensive care unit patients

(2012) Salmaan Kanji et al.   JOURNAL OF CRITICAL CARE

Terlipressin Decreases Vascular Endothelial Growth Factor Expression and Improves Oxygenation in Patients with Acute Respiratory Distress Syndrome and Shock

(2012) Feng Hua et al.   JOURNAL OF EMERGENCY MEDICINE

Pharmacological Characterization of FE 202158, a Novel, Potent, Selective, and Short-Acting Peptidic Vasopressin V1a Receptor Full Agonist for the Treatment of Vasodilatory Hypotension

(2011) R. Laporte et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Fluid resuscitation in septic shock: A positive fluid balance and elevated central venous pressure are associated with increased mortality*

(2010) John H. Boyd et al.   CRITICAL CARE MEDICINE

Effects of two different dosing regimens of terlipressin on organ functions in ovine endotoxemia

(2010) Matthias Lange et al.   INFLAMMATION RESEARCH

Comparison of Dopamine and Norepinephrine in the Treatment of Shock

(2010) Daniel De Backer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Terlipressin: a promising vasoactive agent in hemodynamic support of septic shock

(2009) Andrea Morelli et al.   EXPERT OPINION ON PHARMACOTHERAPY

174 CLINICAL EFFICACY AND SAFETY OF TERLIPRESSIN ADMINISTRATION IN CIRRHOTIC PATIENTS WITH SEPTIC SHOCK

(2009) J.G. Acevedo et al.   JOURNAL OF HEPATOLOGY

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE

Sympathetic Overstimulation During Critical Illness: Adverse Effects of Adrenergic Stress

(2009) Martin W. Dünser et al.   JOURNAL OF INTENSIVE CARE MEDICINE

Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: the DOBUPRESS study † †This study was performed in the Intensive Care Unit of the Department of Anesthesiology and Intensive Care of the University of Rome, ‘La Sapienza’.

(2008) A. Morelli et al.   BRITISH JOURNAL OF ANAESTHESIA

A comparison of epinephrine and norepinephrine in critically ill patients

(2008) John A. Myburgh et al.   INTENSIVE CARE MEDICINE

Terlipressin infusion induces ischemia of breast skin in a cirrothic patient with hepatorenal syndrome

(2007) A. Di Micoli et al.   DIGESTIVE AND LIVER DISEASE